Proceedings of the National Academy of Sciences · 1994 · 843 citations · 41 references
MedicineMolecular BiologyOncologyCarcinogenesisEpigeneticsGene ExpressionBenign Prostatic HyperplasiaDna Methylation ProfilingProstate CancerProstate PathologyProstatic PathologyTumor MarkersCancer Cell Line ModelsGenomic Alteration ProfilingGlutathione S-transferase ActivityPromoter Consensus SequencesProstate CarcinogenesisProstatic AdenocarcinomaRegulatory Sequences
Hypermethylation of regulatory sequences at the locus of the pi-class glutathione S-transferase gene GSTP1 was detected in 20 of 20 human prostatic carcinoma tissue specimens studied but not in normal tissues or prostatic tissues exhibiting benign hyperplasia. In addition, a striking decrease in GSTP1 expression was found to accompany human prostatic carcinogenesis. Immunohistochemical staining with anti-GSTP1 antibodies failed to detect the enzyme in 88 of 91 prostatic carcinomas analyzed. In vitro, GSTP1 expression was limited to human prostatic cancer cell lines containing GSTP1 alleles with hypomethylated promoter sequences; a human prostatic cancer cell line containing only hypermethylated GSTP1 promoter sequences did not express GSTP1 mRNA or polypeptides. Methylation of cytidine nucleotides in GSTP1 regulatory sequences constitutes the most common genomic alteration yet described for human prostate cancer.
41
LNCaP model of human prostatic carcinoma.
Julius S. Horoszewicz, Susan S. Leong, Elzbieta Kawinski et al. · PubMed · 1983 · 1.8K citations
Medicine, Cancer Biology, Oncology +15
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn Me, Narayan Ks, Yuko Ohnuki et al. · PubMed · 1979 · 1.6K citations